RESEARCH AND DEVELOPMENT
Currently, Matrix Biomed, Inc. gene-based therapeutics has produced drug products with two main objectives : 1) increase the efficacy of current cancer treatment regimens and 2) decrease side effects of chemotherapy and radiation. By targeting the master genes responsible for cancer development and progression (HIF-1 and HIF-2), Matrix Biomed, Inc. is poised to transform cancer treatment.
Current Clinical Trial Development
![clinical-programs_page_1 clinical-programs_page_1](http://matrixbiomed.com/wp-content/uploads/2021/03/clinical-programs_page_1.jpg)